Everactive has rebranded from PsiKick and secured $30m from investors including ABB Technology Ventures to boost its total funding to $63m.
Month: June 2019
Corporates to enrich Paytm Money with $1.2bn
Ant Financial and SoftBank have expressed interest in backing a $1.2bn funding round for Paytm Money, the wealth management subsidiary of their portfolio company One97 Communications.
Prevail sails to $125m IPO
The AbbVie Ventures-backed neurodegenerative disease treatment developer floated in the middle of its range having previously raised $129m in funding.
BioSerenity eases its way to series B stage
Dassault Systèmes has led a $56.5m series B round for health monitor developer BioSerenity, which also welcomed back return investors Idinvest Partners, LBO France and BPIfrance.
Rapt Therapeutics raises series C round $97m
The cancer immunotherapy developer has added $37m to increase a series C round featuring Celgene and Alphabet unit GV to $97m.
Valimail posts $45m series C
The email authentication software provider plans to grow its global footprint with a series C round featuring returning investor Bloomberg Beta and has now raised almost $84m in total.
Optimizely orchestrates $50m series D round
The website optimisation tools provider increased its overall funding to $200m with an Accenture-backed series D round secured alongside a $55m credit facility from Bridge Bank.
GoTenna attracts corporates for $24m series C
Off-grid mobile communications technology provider GoTenna has won the backing of Bloomberg Beta and Comcast Ventures to take its overall funding haul to nearly $41m.
Capstone connects to $42m fund
Korea Telecommunications Operators Association is among the limited partners in a $42m fund aimed at technologies such as artificial intelligence, big data and 5G networks.
Xiaomi forms $29m venture firm
The smartphone maker has launched a $29m VC and consulting business subsidiary based in the Chinese city of Chongqing.
Stoke Therapeutics sticks landing on $142m IPO
The Alexandria Venture Investments-backed genetic disease therapy developer is floating above its range having increased the number of shares in the offering.
Wu takes cue at Alibaba Innovation Ventures
Chief financial officer Maggie Wu has been put in charge of strategic acquisitions and investments at Alibaba, replacing executive vice-chairman Joe Tsai.
Catalys Pacific catches $100m for debut fund
Chugai, Eisai, SoftBank, Takeda and Celgene have contributed to healthcare venture firm Catalys Pacific’s inaugural fund, which has a target size of $100m.
AnyVision achieves $74m series A close
AI-equipped camera technology provider AnyVision added $31m to close the Robert Bosch, M12 and Qualcomm Ventures-backed round.